Risk Scores For VAD Implantation

Since there are very few prospective trials in patients who undergo LVAD placement as bridge to transplantation (BTT) and very little data on the long-term use of MCS as a permanent alternative to heart transplantation (HT), or destination therapy (DT) , most of the patient selection criteria for LVAD therapy, including the criteria for DT published by the U.S. Centers for Medicare and Medicaid Services are very broad and based on clinical experiences of single centers and data collected by large multiinstitutional registries.